Article
Novartis buys Chinook for $3.5 billion in race to treat rare kidney disease
Rating:
0.0
Views:
36
Likes:
1
Library:
1
Novartis said it has agreed to acquire U.S. biotech firm Chinook Therapeutics for up to $3.5 billion to boost its late-stage drug development line-up, raising the stakes in the race for a rare kidney disease treatment.
Rate This Post
Rate The Educational Value
Rate The Ease of Understanding and Presentation
Interesting or Boring? Rate the Entertainment Value